191 related articles for article (PubMed ID: 23197643)
1. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.
Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV
Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ
Blood; 2011 Jan; 117(3):1053-60. PubMed ID: 21088133
[TBL] [Abstract][Full Text] [Related]
3. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
Guillot PV; Abass O; Bassett JH; Shefelbine SJ; Bou-Gharios G; Chan J; Kurata H; Williams GR; Polak J; Fisk NM
Blood; 2008 Feb; 111(3):1717-25. PubMed ID: 17967940
[TBL] [Abstract][Full Text] [Related]
6. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model.
Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I
Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
8. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.
Otsuru S; Gordon PL; Shimono K; Jethva R; Marino R; Phillips CL; Hofmann TJ; Veronesi E; Dominici M; Iwamoto M; Horwitz EM
Blood; 2012 Aug; 120(9):1933-41. PubMed ID: 22829629
[TBL] [Abstract][Full Text] [Related]
9. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
Li F; Wang X; Niyibizi C
Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236
[TBL] [Abstract][Full Text] [Related]
10. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells.
Lien CY; Chih-Yuan Ho K; Lee OK; Blunn GW; Su Y
J Bone Miner Res; 2009 May; 24(5):837-48. PubMed ID: 19113920
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced Osteogenesis and Adipogenesis in Mice Deficient in the Chemokine Cxcl12/Sdf1 in the Bone Mesenchymal Stem/Progenitor Cells.
Tzeng YS; Chung NC; Chen YR; Huang HY; Chuang WP; Lai DM
J Bone Miner Res; 2018 Apr; 33(4):679-690. PubMed ID: 29120093
[TBL] [Abstract][Full Text] [Related]
12. Counteracting bone fragility with human amniotic mesenchymal stem cells.
Ranzoni AM; Corcelli M; Hau KL; Kerns JG; Vanleene M; Shefelbine S; Jones GN; Moschidou D; Dala-Ali B; Goodship AE; De Coppi P; Arnett TR; Guillot PV
Sci Rep; 2016 Dec; 6():39656. PubMed ID: 27995994
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype.
Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I
Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429
[TBL] [Abstract][Full Text] [Related]
14. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
Wang X; Li F; Niyibizi C
Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597
[TBL] [Abstract][Full Text] [Related]
15. Role of the HIF‑1α/SDF‑1/CXCR4 signaling axis in accelerated fracture healing after craniocerebral injury.
Xue Y; Li Z; Wang Y; Zhu X; Hu R; Xu W
Mol Med Rep; 2020 Oct; 22(4):2767-2774. PubMed ID: 32945380
[TBL] [Abstract][Full Text] [Related]
16. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
[TBL] [Abstract][Full Text] [Related]
17. SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing.
Kawakami Y; Ii M; Matsumoto T; Kuroda R; Kuroda T; Kwon SM; Kawamoto A; Akimaru H; Mifune Y; Shoji T; Fukui T; Kurosaka M; Asahara T
J Bone Miner Res; 2015 Jan; 30(1):95-105. PubMed ID: 25130304
[TBL] [Abstract][Full Text] [Related]
18. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
19. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model.
Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S
Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311
[TBL] [Abstract][Full Text] [Related]
20. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
